These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24154881)

  • 1. Coexistence of cardiomyopathy and pericardial effusion: A challenging diagnosis.
    Yalcinkaya E
    Herz; 2014 Mar; 39(2):224. PubMed ID: 24154881
    [No Abstract]   [Full Text] [Related]  

  • 2. Coexistence of cardiomyopathy and pericardial effusion: A challenging diagnosis. Reply.
    Omar HR
    Herz; 2014 Mar; 39(2):225. PubMed ID: 24812687
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycoprotein IIb/IIIa antagonists in Takotsubo cardiomyopathy.
    Omar HR
    Herz; 2013 Nov; 38(7):740-2. PubMed ID: 23632423
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac tamponade complicating myocardial infarction in the era of thrombolytics and platelet IIb/IIIa: case report and literature review.
    Mixon TA; Tak T; Lawrence ME
    Am J Geriatr Cardiol; 2001; 10(3):133-8. PubMed ID: 11360837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transvenous pacing causing tamponade in patients receiving glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention.
    Jeilan M; Richardson G; Gershlick A
    J Invasive Cardiol; 2007 Feb; 19(2):E40-2. PubMed ID: 17268050
    [No Abstract]   [Full Text] [Related]  

  • 6. Takotsubo cardiomyopathy complicated by cardiac tamponade due to non-hemorrhagic pericardial effusion: a case report.
    Nagamori Y; Hamaoka T; Murai H; Takashima S; Kato T; Usui S; Sakata K; Furusho H; Kawashiri M; Takamura M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):67. PubMed ID: 32028901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of action of GpIIb-IIIa antagonists.
    Johnson K
    Crit Care Nurse; 2000 Oct; 20(5):16. PubMed ID: 11878484
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet inhibition after glycoprotein IIb/IIIa inhibitor therapy.
    Galli M
    Circulation; 2001 Dec; 104(25):E163. PubMed ID: 11748127
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing platelet function during treatment with glycoprotein IIb/IIIa antagonists.
    Steinhubl SR
    Coron Artery Dis; 2003 Aug; 14(5):381-6. PubMed ID: 12878903
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of BP IIb/IIIa inhibitors].
    Polimeno S; De Rosa V
    Ital Heart J Suppl; 2000 Jul; 1(7):958-61. PubMed ID: 10935749
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathophysiology, clinical and experimental possibilities of pericardial tamponade].
    Bari G; Érces D; Varga G; Szűcs S; Bogáts G
    Orv Hetil; 2018 Feb; 159(5):163-167. PubMed ID: 29376423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitors of platelet glycoprotein IIb-IIIa in cardiology].
    Obradović S; Gligić B; Djordjević D; Jovicić A; Romanović R; Ratković N; Dincić D; Orozović V; Nikolić G
    Vojnosanit Pregl; 2001; 58(1):65-72. PubMed ID: 11419288
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antagonists of the GPIIb/IIIa platelet receptor].
    Gomes ME; Fabris C; B filho JL; Dreher R; Rosito GA
    Rev Assoc Med Bras (1992); 2000; 46(3):255-64. PubMed ID: 11070517
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease.
    Chesebro JH; Badimon JJ
    N Engl J Med; 1998 May; 338(21):1539-41. PubMed ID: 9593795
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring platelet function in glycoprotein IIB/IIIA inhibitor therapy.
    Wu KK; Willerson JT
    Circulation; 2001 May; 103(21):2528-30. PubMed ID: 11382717
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes.
    Zidar JP
    J Invasive Cardiol; 1999 Jun; 11 Suppl A():13A-19A. PubMed ID: 10745606
    [No Abstract]   [Full Text] [Related]  

  • 17. Do Glycoprotein IIb/IIIa Inhibitors Improve Outcomes in Acute Ischemic Stroke?
    Ganti L
    Ann Emerg Med; 2015 Jul; 66(1):65-6. PubMed ID: 25724622
    [No Abstract]   [Full Text] [Related]  

  • 18. [GPIIb/IIIa inhibitor].
    Ikeda Y
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1174-81. PubMed ID: 10771692
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of acute central retinal artery occlusionwith the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban.
    Hölschermann H; Krombach C; Jung A; Jacobi F; Tillmanns H; Weinand F
    Thromb Haemost; 2005 Sep; 94(3):684-6. PubMed ID: 16268493
    [No Abstract]   [Full Text] [Related]  

  • 20. GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood.
    Furman MI; Krueger LA; Frelinger AL; Barnard MR; Mascelli MA; Nakada MT; Michelson AD
    Thromb Haemost; 2000 Sep; 84(3):492-8. PubMed ID: 11019977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.